Search research articles
Contact Us
Filters
Showing results (11-20 of 92) with videos related to
Page
of 10
Sort By:
Molecular Biology and Evolution
|
August 22, 2024
Inference of Host-Pathogen Interaction Matrices from Genome-Wide Polymorphism Data
Hanna Märkle, Sona John, Lukas Metzger, et al.
Gut
|
May 25, 2022
Defining the key intrahepatic gene networks in HCV infection driven by sex
Emanuele Marchi, Narayan Ramamurthy, M Azim Ansari, et al.
The Journal of General Virology
|
March 6, 2020
Analysis of genomic-length HBV sequences to determine genotype and subgenotype reference sequences
Anna L McNaughton, Peter A Revill, Margaret Littlejohn, et al.
Computers in Biology and Medicine
|
July 4, 2024
Current strategies to address data scarcity in artificial intelligence-based drug discovery: A comprehensive review
Amit Gangwal, Azim Ansari, Iqrar Ahmad, et al.
Journal of Viral Hepatitis
|
April 24, 2021
Global prevalence and phylogeny of hepatitis B virus (HBV) drug and vaccine resistance mutations
Jolynne Mokaya, Tetyana I Vasylyeva, Eleanor Barnes, et al.
Frontiers in Pharmacology
|
February 22, 2024
Generative artificial intelligence in drug discovery: basic framework, recent advances, challenges, and opportunities
Amit Gangwal, Azim Ansari, Iqrar Ahmad, et al.
RNA (New York, N.Y.)
|
August 5, 2020
Impact of virus subtype and host <i>IFNL4</i> genotype on large-scale RNA structure formation in the genome of hepatitis C virus
Peter Simmonds, Lize Cuypers, Will L Irving, et al.
Journal of Biomolecular Structure & Dynamics
|
August 31, 2023
Dual targeting in prostate cancer with phytoconstituents as a potent lead: a computational approach for novel drug discovery
Sachin A Dhawale, Pallavi Bhosle, Sadhana Mahajan, et al.
Frontiers in Medicine
|
September 7, 2021
Risk of Reactivation of Hepatitis B Virus (HBV) and Tuberculosis (TB) and Complications of Hepatitis C Virus (HCV) Following Tocilizumab Therapy: A Systematic Review to Inform Risk Assessment in the COVID-19 Era
Cori Campbell, Monique I Andersson, M Azim Ansari, et al.
PLOS Global Public Health
|
March 24, 2023
A systematic review of Hepatitis B virus (HBV) prevalence and genotypes in Kenya: Data to inform clinical care and health policy
Louise O Downs, Cori Campbell, Paul Yonga, et al.
Page
of 10
Search research articles
Search
Showing results (11-20 of 92) with videos related to
Sort By:
Page
of 10
Molecular Biology and Evolution
|
August 22, 2024
Inference of Host-Pathogen Interaction Matrices from Genome-Wide Polymorphism Data
Hanna Märkle, Sona John, Lukas Metzger, et al.
Gut
|
May 25, 2022
Defining the key intrahepatic gene networks in HCV infection driven by sex
Emanuele Marchi, Narayan Ramamurthy, M Azim Ansari, et al.
The Journal of General Virology
|
March 6, 2020
Analysis of genomic-length HBV sequences to determine genotype and subgenotype reference sequences
Anna L McNaughton, Peter A Revill, Margaret Littlejohn, et al.
Computers in Biology and Medicine
|
July 4, 2024
Current strategies to address data scarcity in artificial intelligence-based drug discovery: A comprehensive review
Amit Gangwal, Azim Ansari, Iqrar Ahmad, et al.
Journal of Viral Hepatitis
|
April 24, 2021
Global prevalence and phylogeny of hepatitis B virus (HBV) drug and vaccine resistance mutations
Jolynne Mokaya, Tetyana I Vasylyeva, Eleanor Barnes, et al.
Frontiers in Pharmacology
|
February 22, 2024
Generative artificial intelligence in drug discovery: basic framework, recent advances, challenges, and opportunities
Amit Gangwal, Azim Ansari, Iqrar Ahmad, et al.
RNA (New York, N.Y.)
|
August 5, 2020
Impact of virus subtype and host <i>IFNL4</i> genotype on large-scale RNA structure formation in the genome of hepatitis C virus
Peter Simmonds, Lize Cuypers, Will L Irving, et al.
Journal of Biomolecular Structure & Dynamics
|
August 31, 2023
Dual targeting in prostate cancer with phytoconstituents as a potent lead: a computational approach for novel drug discovery
Sachin A Dhawale, Pallavi Bhosle, Sadhana Mahajan, et al.
Frontiers in Medicine
|
September 7, 2021
Risk of Reactivation of Hepatitis B Virus (HBV) and Tuberculosis (TB) and Complications of Hepatitis C Virus (HCV) Following Tocilizumab Therapy: A Systematic Review to Inform Risk Assessment in the COVID-19 Era
Cori Campbell, Monique I Andersson, M Azim Ansari, et al.
PLOS Global Public Health
|
March 24, 2023
A systematic review of Hepatitis B virus (HBV) prevalence and genotypes in Kenya: Data to inform clinical care and health policy
Louise O Downs, Cori Campbell, Paul Yonga, et al.
Page
of 10